Menu
Back to Journals » International Journal of General Medicine » Volume 10
Commentary
Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,300 | Dovepress* | 11,758+ | 2,404 | 14,162 | |
| PubMed Central* | 5,542 | 1,057 | 6,599 | ||
| Totals | 17,300 | 3,461 | 20,761 | ||
| *Since 13 January 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar